Adsoption of two vaccine-related proteins to montmorillonite and organo-montmorillonite

Applied Clay Science

Volumn 50, Issue 4, 2010, Pages 569-575

  Rytwo, Giora ^a,b   Mendelovits, Asaf ^a,c   Eliyahu, Dalia ^b   Pitcovski, Jacob ^a,b   Aizenshtein, Elina ^b  

^a TEL HAI COLLEGE   (Israel)

^b MIGAL GALILEE TECHNOLOGY CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Adsorption; Berberine; Montmorillonite; Organoclay; Protein; Vaccination

Indexed keywords

BERBERINE; BIOLOGICAL ASSAYS; IMMUNE RESPONSE; IMMUNOGENICITY; MINERAL PARTICLES; MONTMORILLONITE; ORAL ADMINISTRATION; ORGANO-MONTMORILLONITE; POULTRY INDUSTRY; VACCINATION; VACCINE CARRIERS; VIRAL PROTEINS;

ADSORPTION; GENETIC ENGINEERING; IMMUNOLOGY; MINERALS; ORGANOCLAY; PROTEINS; SILICATE MINERALS; VACCINES;

CLAY MINERALS;

ADSORPTION; IMMUNE RESPONSE; MONTMORILLONITE; ORGANOCLAY; PROTEIN; VACCINATION;

AVES;

EID: 78649449746     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2010.10.015     Document Type: Article

References (42)

1. Aguzzi C., Cerezo P., Viseras C., Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007, 36:22-36.
2. Arrondo J.L., Muga A., Castresana J., Goni F.M. Quantitative studies of the structure of proteins in solution by Fourier-transform infrared spectroscopy. Prog. Biophys. Mol. Biol. 1993, 59:23-56.
3. Blade W.H., Boulton R. Adsorption of protein by bentonite in a model wine solution. Am. J. Enol. Vitic. 1988, 39:193-199.
4. Boyaka P.N., Marinaro M., Vancott J.L., Takahashi I., Fujihash K., Yamamoto M., van Ginkel F.W., Jackson R.J., Kiyono H., McGhee J.R. Strategies for mucosal vaccine development. Am. J. Trop. Med. Hyg. 1999, 60:35-45.
5. Clements J.D., Yancey R.J., Finkelstein R.A. Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect. Immun. 1980, 29:91-97.
6. Cohen E., Joseph T., Wassermann-Golan M. Photostabilization of biocontrol agents by berberine. Int. J. Pest Manage. 2001, 47:63-67.
7. Connell T.D. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins. Expert Rev. Vaccines. 2007, 6:821-834.
8. Cox E., Verdonck F., Vanrompay D., Goddeeris B. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet. Res. 2006, 37:511-539.
9. Cypes S.H., Saltzman W.M., Giannelis E.P. Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties. J. Controlled Release 2003, 90:163-169.
10. Ernst P.B., Song F., Klimpel G.R., Haeberle H., Bamford K.B., Crowe S.E., Ye G., Reyes V.E. Regulation of the mucosal immune response. Am. J. Trop. Med. Hyg. 1999, 60:2-9.
11. Feil I.K., Reddy R., de Haan L., Merritt E.A., Van den Akker F., Storm D.R., Hol W.G.J. Protein engineering studies of Achain loop 47-56 of Escherichia coli heat-labile enterotoxin point to a prominent role of this loop for cytotoxicity. Mol. Microbiol. 1996, 20:823-832.
12. Fingerut E., Gutter B., Meir R., Eliahoo D., Pitcovski J. Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast. Vaccine 2005, 23:4685-4696.
13. Fukuta S., Magnani J.L., Twiddy E.M., Holmes R.K., Ginsburg V. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-Iib. Infect. Immun. 1988, 56:1748-1753.
14. Fusi P., Ristort G.G., Calamai L., Stotzky G. Adsorption and binding of protein on 'clean' (homoionic) and 'dirty' (coated with Fe oxyhydroxides) montmorillonite, illite and kaolinite. Soil Biol. Biochem. 1989, 21:911-920.
15. Gasparini R., Pozzi T., Montomoli E., Fragapane E., Senatore F., Minutello M., Podda A. Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects. Eur. J. Epidemiol. 2001, 17:135-140.
16. Glenn G.M., Francis D.H., Danielsen E.M. Toxin-mediated effects on the innate mucosal defenses: implications for enteric vaccines. Infect. Immun. 2009, 77:5206-5215.
17. Hagiwar Y., Tsuji T., Iwasaki T., Kadowaki S., Asanuma H., Chen Z., Komase K., Suzuki Y., Aizawa C., Kurata T., Tamura S. Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine. Vaccine 2001, 19:2071-2079.
18. Harter R.D., Stotzky G. Formation of clay-protein complexes. Soil Sci. Soc. Am. Proc. 1971, 35:383-389.
19. Harter R.D., Stotzky G. X-ray diffraction, electron microscopy, electrophoretic mobility, and pH of some stable smectite-protein complexes. Soil Sci. Soc. Am. Proc. 1973, 37:116-123.
20. Holmgren J., Lindblad M., Fredman P., Svennerholm L., Myrvold H. Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology 1985, 89:27-35.
21. Kong J., Yu S. Fourier transform infrared spectroscopic analysis of protein secondary structure (Review). Acta Biochim. Biophys. Sin. 2007, 39(8):549-559.
22. Lin F., Chen C., Cheng W.T.K., Kuo T. Modified montmorillonite as vector for gene delivery. Biomaterials 2006, 27:3333-3338.
23. McGhee J.R., Mestecky J., Derzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10:75-88.
24. Pitcovski J., Di-Castro D., Shaaltiel Y., Gutter B., Yarkoni E., Michael A., Krispel S., Levi B.Z. Insect cell-derived VP2 of infectious bursal disease virus confers protection against the disease in chickens. Avian Dis. 1996, 40:753-761.
25. Pitcovski J., Gutter B., Gallili G., Goldway M., Perelman B., Gross G., Krispel S., Barbakov M., Michael A. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 2003, 21:4736-4743.
26. Ruiz-Hitzky E., Darder M., Aranda P. Functional biopolymer nanocomposites based on layered solids. J. Mater. Chem. 2005, 15:3650-3662.
27. Ruiz-Hitzky E., Darder M., Aranda P., d.Burgo M.Á.M., d.Real G. Bionanocomposites as new carriers for influenza vaccines. Adv. Mater. 2009, 21:4167-4171.
28. Rytwo G., Serban C., Nir S., Margulies L. Use of methylene blue and crystal violet for determination of exchangeable cations in montmorillonite. Clays Clay Miner. 1991, 39:551-555.
29. Rytwo G., Huterer-Harari R., Dultz S., Gonen Y. Adsorption of fast green and erythrosin-B to montmorillonite modified with crystal violet. J. Therm. Anal. Calorim. 2006, 84:225-231.
30. Rytwo G., Gonen Y., Afuta S. Preparation of berberine-montmorillonite-metolachlor formulations from hydrophobic/hydrophilic mixtures. Appl. Clay Sci. 2008, 41:47-60.
31. Singh M., O'Hagan D. Advances in vaccine adjuvants. Nat. Biotechnol. 1999, 17:1075-1081.
32. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 1992, 56:622-647.
33. Sugii S., Tsuji T. Binding specificities of heat-labile enterotoxins isolated from porcine and human enterotoxigenic Escherichia coli for different gangliosides. Can. J. Microbiol. 1989, 35:670-673.
34. Susi H., Byler D.M. Protein structure by Fourier transform infrared spectroscopy: second derivative spectra. Biochem. Biophys. Res. Commun. 1983, 115:391-397.
35. Susi H., Byler D.M. Resolution-enhanced Fourier transform infrared spectroscopy of enzymes. Methods Enzymol. 1986, 130:290-311.
36. Theng B.K.G. Formation and Properties of Clay-Polymer Complexes 1979, Elsevier Sci. Pub, New York.
37. Tripathy D.N. The impact of vaccines and the future of genetically modified poxvirus vaccines for poultry. Anim. Health Res. Rev. 2004, 5:263-266.
38. Vakharia V.N., Snyder D.B., Lutticken D., Mengel-Whereat S.A., Savage P.K., Edwards G.H., Goodwin M.A. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins. Vaccine 1994, 12:452-456.
39. Vasserman Y., Pitcovski J. Genetic detoxification and adjuvant-activity retention of Escherichia coli enterotoxin LT. Avian Pathol. 2006, 35:134-140.
40. Wang X., Du Y., Luo J. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 2008, 19:065707. 7pp.
41. Wei J., Lin Y., Zhou J., Tsou C. FTIR studies of secondary structures of bovine insulin and its derivatives. Biochim. Et Biophys. Acta BBA Protein Struct. Mol. Enzymology. 1991, 1080:29-33.
42. Wyeth P.J., Cullen G.A. Maternally derived antibody-effect on susceptibility of chicks to infectious bursal disease. Avian Pathol. 1976, 5:253-260.